Vanessa González-Covarrubias

Author

National Institute of Genomic Medicine ORCID

Also Known As

Gonzalez-Covarrubias, Vanessa, V., Gonzalez-Covarrubias, Vanessa Gonzalez-Covarrubias, Vanessa Gonzalez-Covarrubiasa, Vanessa Gonzalez‐Covarrubias, Vanessa Gonzlez-Covarrubias, Vanessa González Covarrubias, Vanessa González-Covarrubias, Vanessa M. Gonzalez‐Covarrubias

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Institute of Genomic Medicine University at Buffalo, State University of New York Universidad Nacional Autónoma de México Universidad Veracruzana Secretaria de Salud

About

Vanessa González-Covarrubias is an author at National Institute of Genomic Medicine specializing in medicine, pharmacology, and genetic epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	384
2	Public Health	2	2	26
3	Health Sciences	1	1	178
4	Natural Sciences	1	1	37
5	Biochemistry	1	1	37

Vanessa González-Covarrubias

Publications

950

Citations

H-Index

Page 1

	Year	Citations
Genetic polymorphisms in the carbonyl reductase 3 gene <i>CBR3</i> and the NAD(P)H:quinone oxidoreductase 1 gene <i>NQO1</i> in patients who developed anthracycline‐related congestive heart failure after childhood cancer Javier G. Blanco, Wendy M. Leisenring, Vanessa González-Covarrubias, Cancer	2008	218
Lipidomics of familial longevity Vanessa González-Covarrubias, Marian Beekman, Hae‐Won Uh, Aging Cell AgingLipid SpeciesFemale Reproductive FunctionOxidative StressMetabolic Syndrome	2013	178
The influence of citrate, EDTA, and heparin anticoagulants to human plasma LC–MS lipidomic profiling Vanessa González-Covarrubias, Adrie Dane, Thomas Hankemeier, Metabolomics Heparin AnticoagulantsHuman Plasma Lc–msMedicineBioanalysisHematology	2012	70
A Functional Genetic Polymorphism on Human Carbonyl Reductase 1 (CBR1 V88I) Impacts on Catalytic Activity and NADPH Binding Affinity Vanessa González-Covarrubias, Debashis Ghosh, Sukhwinder S. Lakhman, Drug Metabolism and Disposition	2007	61
Pharmacogenetics of Human Carbonyl Reductase 1 (CBR1) in Livers from Black and White Donors Vanessa González-Covarrubias, Jianping Zhang, James Kalabus, Drug Metabolism and Disposition	2008	39
SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanisms Pilar García-Tobilla, Susana R. Solórzano, Iván Salido-Guadarrama, Gene ChromatinDifferent Epigenetic MechanismsEpigenetic ChangeSfrp1 RepressionTumor Suppressor	2016	38
Inhibition of Polymorphic Human Carbonyl Reductase 1 (CBR1) by the Cardioprotectant Flavonoid 7-monohydroxyethyl Rutoside (monoHER) Vanessa González-Covarrubias, James Kalabus, Javier G. Blanco Pharmaceutical Research Reductive StressMedicinal ChemistryChemoprevention StrategyBiochemistryMedicine	2008	37
Functional Characterization of the Promoter of Human Carbonyl Reductase 1 (CBR1). Role of XRE Elements in Mediating the Induction of CBR1 by Ligands of the Aryl Hydrocarbon Receptor Sukhwinder S. Lakhman, Vanessa González-Covarrubias, Erin G. Schuetz, Molecular Pharmacology	2007	36
Anthocyanins of Blue Corn and Tortilla Arrest Cell Cycle and Induce Apoptosis on Breast and Prostate Cancer Cells Mónica Herrera-Sotero, Carlos D. Cruz-Hernández, Rosa María Oliart‐Ros, Nutrition and Cancer	2019	33
Whole genomic sequencing as a tool for diagnosis of drug and multidrug-resistance tuberculosis in an endemic region in Mexico Carlos Francisco Madrazo-Moya, Irving Cancino‐Muñoz, Betzaida Cuevas-Córdoba, PLoS ONE	2019	30

Page 1